Andrew E. Greenstein

1.5k total citations
37 papers, 1.1k citations indexed

About

Andrew E. Greenstein is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Andrew E. Greenstein has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Andrew E. Greenstein's work include Hepatitis C virus research (7 papers), Protease and Inhibitor Mechanisms (5 papers) and Hepatitis B Virus Studies (5 papers). Andrew E. Greenstein is often cited by papers focused on Hepatitis C virus research (7 papers), Protease and Inhibitor Mechanisms (5 papers) and Hepatitis B Virus Studies (5 papers). Andrew E. Greenstein collaborates with scholars based in United States, United Kingdom and Italy. Andrew E. Greenstein's co-authors include Tom Alber, Victoria Smith, T. Noelle Lombana, Nathaniel Echols, Margaret Robinson, Yury Popov, Zhenwei Peng, Susan B. Liu, Naoki Ikenaga and Deanna Sverdlov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Andrew E. Greenstein

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew E. Greenstein United States	17	497	295	241	225	181	37	1.1k
Kazunori Kajino Japan	21	447 0.9×	512 1.7×	149 0.6×	453 2.0×	183 1.0×	70	1.2k
Martin K. Thomsen Denmark	23	992 2.0×	286 1.0×	207 0.9×	99 0.4×	241 1.3×	45	1.8k
Dianxing Sun China	17	399 0.8×	448 1.5×	105 0.4×	337 1.5×	187 1.0×	45	1.1k
Chuanlong Zhu China	21	473 1.0×	473 1.6×	117 0.5×	384 1.7×	99 0.5×	77	1.3k
Hien Dang United States	16	684 1.4×	130 0.4×	109 0.5×	156 0.7×	296 1.6×	28	1.2k
Joachim Lupberger France	19	484 1.0×	626 2.1×	104 0.4×	582 2.6×	136 0.8×	37	1.4k
Elena Fernández‐Ruiz Spain	24	598 1.2×	386 1.3×	201 0.8×	154 0.7×	255 1.4×	44	2.1k
Pamela A. Norton United States	27	1.1k 2.2×	409 1.4×	83 0.3×	295 1.3×	206 1.1×	56	2.2k
G. Spira Israel	21	673 1.4×	410 1.4×	200 0.8×	276 1.2×	208 1.1×	49	1.5k
Yaoyu E. Wang United States	21	854 1.7×	123 0.4×	166 0.7×	58 0.3×	368 2.0×	35	1.6k

Countries citing papers authored by Andrew E. Greenstein

Since Specialization

Citations

This map shows the geographic impact of Andrew E. Greenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Greenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Greenstein more than expected).

Fields of papers citing papers by Andrew E. Greenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew E. Greenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Greenstein. The network helps show where Andrew E. Greenstein may publish in the future.

Co-authorship network of co-authors of Andrew E. Greenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew E. Greenstein. A scholar is included among the top collaborators of Andrew E. Greenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew E. Greenstein. Andrew E. Greenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Colombo, Nicoletta, Toon Van Gorp, Ursula A. Matulonis, et al.. (2023). Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study. Journal of Clinical Oncology. 41(30). 4779–4789. 16 indexed citations

O’Sullivan, Chris, Robert Brockett, Amanda Mikels‐Vigdal, et al.. (2023). Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody. Antibodies. 12(1). 9–9. 11 indexed citations

Chakrabarti, Jayati, Jennifer Eschbacher, Andreas Moraitis, et al.. (2023). Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators. Translational research. 256. 56–72. 9 indexed citations

Greenstein, Andrew E. & Hazel Hunt. (2023). The glucocorticoid receptor modulator relacorilant reverses the immunosuppressive effects of cortisol. International Immunopharmacology. 120. 110312–110312. 3 indexed citations

Münster, Pamela N., Andrew E. Greenstein, Gini F. Fleming, et al.. (2022). Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors. Clinical Cancer Research. 28(15). 3214–3224. 20 indexed citations

Allen, Jessica L., et al.. (2022). Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma. Oral Oncology. 132. 106008–106008. 15 indexed citations

Greenstein, Andrew E., Hazel Hunt, Myrthe Mampay, et al.. (2021). An integrated framework for quantifying immune-tumour interactions in a 3D co-culture model. Communications Biology. 4(1). 781–781. 15 indexed citations

Cannataro, Vincent L., Stephen G. Gaffney, Zi-Ming Zhao, et al.. (2018). Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C. Oncogene. 37(18). 2444–2455. 32 indexed citations

O’Sullivan, Chris, Maria Kovalenko, Andrew E. Greenstein, et al.. (2018). MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors. PLoS ONE. 13(11). e0207255–e0207255. 71 indexed citations

10.

Cannataro, Vincent L., Stephen G. Gaffney, Zi-Ming Zhao, et al.. (2017). The Likelihood of Heterogeneity or Additional Mutation to Compromise Targeting of KRAS G12C. Journal of Thoracic Oncology. 12(8). S1538–S1538. 1 indexed citations

11.

Appleby, T.C., Andrew E. Greenstein, Magdeleine Hung, et al.. (2017). Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9. Journal of Biological Chemistry. 292(16). 6810–6820. 76 indexed citations

12.

Han, Bin, Hadas Dvory‐Sobol, Andrew E. Greenstein, et al.. (2015). Development and application of a fast, reproducible assay to measure HCV NS3 protease activity using Escherichia coli lysate. Journal of Virological Methods. 225. 76–86. 3 indexed citations

13.

Greenstein, Andrew E., et al.. (2013). Hepatitis C Viral Entry Inhibitors Prolong Viral Suppression by Replication Inhibitors in Persistently-Infected Huh7 Cultures. PLoS ONE. 8(6). e65273–e65273. 6 indexed citations

14.

Beran, Rudolf K., Amoreena C. Corsa, Tian Yang, et al.. (2012). Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Virus. PLoS ONE. 7(2). e30286–e30286. 18 indexed citations

15.

Lombana, T. Noelle, Nathaniel Echols, Matthew C. Good, et al.. (2010). Allosteric Activation Mechanism of the Mycobacterium tuberculosis Receptor Ser/Thr Protein Kinase, PknB. Structure. 18(12). 1667–1677. 48 indexed citations

16.

Yang, Feng, Jason M. Robotham, Henry Grisé, et al.. (2010). A Major Determinant of Cyclophilin Dependence and Cyclosporine Susceptibility of Hepatitis C Virus Identified by a Genetic Approach. PLoS Pathogens. 6(9). e1001118–e1001118. 79 indexed citations

17.

Greenstein, Andrew E., Jason A. MacGurn, Christina E. Baer, et al.. (2007). M. tuberculosis Ser/Thr Protein Kinase D Phosphorylates an Anti-Anti–Sigma Factor Homolog. PLoS Pathogens. 3(4). e49–e49. 68 indexed citations

18.

Greenstein, Andrew E., Nathaniel Echols, T. Noelle Lombana, David S. King, & Tom Alber. (2007). Allosteric Activation by Dimerization of the PknD Receptor Ser/Thr Protein Kinase from Mycobacterium tuberculosis. Journal of Biological Chemistry. 282(15). 11427–11435. 48 indexed citations

19.

Greenstein, Andrew E., Christoph Grundner, Nathaniel Echols, et al.. (2005). Structure/Function Studies of Ser/Thr and Tyr Protein Phosphorylation in <i>Mycobacterium tuberculosis</i>. Microbial Physiology. 9(3-4). 167–181. 77 indexed citations

20.

Good, Matthew C., Andrew E. Greenstein, Tracy A. Young, Ho Leung Ng, & Tom Alber. (2004). Sensor Domain of the Mycobacterium tuberculosis Receptor Ser/Thr Protein Kinase, PknD, forms a Highly Symmetric β Propeller. Journal of Molecular Biology. 339(2). 459–469. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact